UK and GSK Commit £215 Million to Combat Antimicrobial Resistance with Support from Prince William

May 16, 2024, 02:51 PM

Antimicrobial resistance (AMR) poses a significant global threat, potentially reversing the progress made by antibiotics and other antimicrobials. The UK has announced £85 million in funding to tackle AMR, coinciding with a global event hosted by the Royal Society and following the publication of a new action plan. Additionally, GSK and the UK government are providing £130 million for the new Fleming Initiative, aimed at combating AMR worldwide. The event highlighted the urgent need for collective action and supporting global action, with notable contributions from figures such as Prince William and GSK CEO Emma Walmsley. Global deaths from AMR are nearly 5 million annually, and it also renders pandemics more likely, underscoring the critical need for coordinated efforts to address this public health crisis.